An interventional study of Comorbidities treatment and Auto-DAS in Rheumatoid Arthritis, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-05.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other
The two objectives of this trial are :1 To evaluate the impact of a visit with a nurse checking the preventive modalities and/or the presence of comorbidities such as infections ( e.g. vaccinations), cardiovascular-diseases (e.g. Indication to statin, antiaggregant,anti-hypertensive treatment…), cancers (e.g.mammography,…), osteoporosis (e.g. bone densitometry,..) in patients suffering from Rheumatoid Arthritis 2 To evaluate the impact of an educational program aimed at permitting rheumatoid arthritis patients to auto-evaluate their disease activity by collecting the Disease Activity Score (DAS28-ESR).
Patients with a stable definite Rheumatoid Arthritis will be invited by their rheumatologists to participate at this study in 20 centers in France. After written informed consent will be obtained, the patients will be randomized in two arms:
2,888 studies on the registry are indexed under Arthritis, Rheumatoid; 390 are open to participants now.
This study's enrollment of 970 is above the median of 94 across 1,984 interventional studies indexed under Arthritis, Rheumatoid.
Browse Arthritis, Rheumatoid studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria
"Auto-DAS"Number of patients with a modification in their treatment between baseline and 6 months visits
Behavioral: Auto-DAS
Behavioral: Comorbidities treatment
" Comorbidities treatment":Number of actions initiated in order to treat or prevent Rheumatoid Arthritis comorbidities during the 6 months follow-up
"Auto-DAS"Number of patients with a modification in their treatment between baseline and 6 months visits
Comorbidities treatment
Number of actions initiated I order to treat or prevent Rheumatoid Arthritis comorbidities
Time frame: 6 months later
Auto-DAS: Patient education to calculate his Disease Activity Score
Number of patients with a modification in their treatment between baseline and 6 months visits
Time frame: 6 months after
Frequency of comorbidities in Rheumatoid Arthritis
Time frame: 6 months later
Adhesion to the current recommendations concerning the prevention of co-morbidities
Time frame: 6 months later
Compliance and satisfaction of the patients concerning the DAS educational program
Time frame: 6 months later
Plan to share: No
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris